Close Menu

Precision Medicine Initiative

The law contains provisions that proponents say will advance precision medicine and speed new tests to market, but critics worry if this will come at a cost to public health.

The DiscovEHR study, conducted by the Regeneron Genetics Center and the Geisinger Health System, uncovered many associations between genetic variants and clinical phenotypes.

Eric Dishman, Director, All of Us Research Program

NIH has been conservative on the PMI's budget and its funds are sufficient to launch enrollment next year, begin collecting data, and initiate genetic testing pilot projects.

Personalized medicine proponents are uncertain where funding, personnel, and priorities will land in a new administration and Congress.

A beta-testing community is providing feedback on the PMI's recruitment efforts, which are slated to kick off in the first quarter of 2017.

The healthcare provider organizations are tasked with managing patient enrollment in the Precision Medicine Initiative.

Researchers reported on the impact sequencing projects have already had on participants, as well as the challenges, particularly in data interpretation and storage.

The company has been working with the VA since 2013, when it it received a contract to provide sequencing and data analysis for enrollees in the Million Veteran Program.

Scripps Research Institute, La Jolla, California, aerial view

The institute has also been awarded additional funding from the National Institutes of Health for its increased participation in the initiative.

Proponents believe the Million European Genomes Alliance will spur research, stimulate the life sciences economy, and ultimately improve clinical care.

Pages

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.